| Date | Time | Source | Headline | Symbol | Company |
| 05/31/2024 | 4:47PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:CORT | Corcept Therapeutics Inc |
| 05/31/2024 | 4:46PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:CORT | Corcept Therapeutics Inc |
| 05/31/2024 | 4:45PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:CORT | Corcept Therapeutics Inc |
| 05/31/2024 | 4:44PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:CORT | Corcept Therapeutics Inc |
| 05/31/2024 | 4:43PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:CORT | Corcept Therapeutics Inc |
| 05/31/2024 | 4:41PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:CORT | Corcept Therapeutics Inc |
| 05/31/2024 | 4:40PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:CORT | Corcept Therapeutics Inc |
| 05/31/2024 | 4:39PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:CORT | Corcept Therapeutics Inc |
| 05/31/2024 | 4:38PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:CORT | Corcept Therapeutics Inc |
| 05/31/2024 | 4:38PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:CORT | Corcept Therapeutics Inc |
| 05/31/2024 | 4:38PM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:CORT | Corcept Therapeutics Inc |
| 05/31/2024 | 4:01PM | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee benefit plans | NASDAQ:CORT | Corcept Therapeutics Inc |
| 05/30/2024 | 9:00PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:CORT | Corcept Therapeutics Inc |
| 05/30/2024 | 8:03PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:CORT | Corcept Therapeutics Inc |
| 05/28/2024 | 7:53PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:CORT | Corcept Therapeutics Inc |
| 05/28/2024 | 1:22PM | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NASDAQ:CORT | Corcept Therapeutics Inc |
| 05/28/2024 | 1:14PM | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NASDAQ:CORT | Corcept Therapeutics Inc |
| 05/28/2024 | 8:00AM | GlobeNewswire Inc. | Corcept Announces Primary Endpoint Met in Pivotal Phase 3 GRACE Trial of Relacorilant in Patients With Hypercortisolism (Cushing’s Syndrome) | NASDAQ:CORT | Corcept Therapeutics Inc |
| 05/23/2024 | 4:11PM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:CORT | Corcept Therapeutics Inc |
| 05/21/2024 | 6:47PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:CORT | Corcept Therapeutics Inc |
| 05/21/2024 | 6:42PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:CORT | Corcept Therapeutics Inc |
| 05/21/2024 | 6:41PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:CORT | Corcept Therapeutics Inc |
| 05/21/2024 | 6:30PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:CORT | Corcept Therapeutics Inc |
| 05/21/2024 | 6:28PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:CORT | Corcept Therapeutics Inc |
| 05/21/2024 | 6:25PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:CORT | Corcept Therapeutics Inc |
| 05/21/2024 | 6:25PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:CORT | Corcept Therapeutics Inc |
| 05/21/2024 | 6:08PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:CORT | Corcept Therapeutics Inc |
| 05/15/2024 | 8:32PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:CORT | Corcept Therapeutics Inc |
| 05/13/2024 | 9:32PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:CORT | Corcept Therapeutics Inc |
| 05/13/2024 | 12:24PM | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NASDAQ:CORT | Corcept Therapeutics Inc |